164 results on '"Teimourpour, Amir"'
Search Results
2. Molecular identification of multiple drug resistance (MDR) strain of Mycobacterium tuberculosis
3. Influential factors on stem cell therapy success in canine model of spinal cord Injury: A systematic review and meta-analysis
4. The return rate of deferred blood donors in Iran
5. Frequency, clinical, and laboratory findings of platelet secretion disorders in patients referred to the specialized coagulation laboratory of the Iranian Blood Transfusion Organization
6. Utility of the international society on thrombosis and hemostasis-bleeding assessment tool in the diagnosis of patients who suspected of platelet function disorders
7. Probiotic supplement as an adjunctive therapy with Ritalin for treatment of attention-deficit hyperactivity disorder symptoms in children: a double-blind placebo-controlled randomized clinical trial
8. Estimate of anti-SARS-CoV-2 spike IgG antibodies prevalence among Iranian population based on blood donations: A serial cross-sectional study during the third wave of the pandemic
9. Multi-lead ECG heartbeat classification of heart disease based on HOG local feature descriptor
10. Molecular detection and characterization of Shigella spp. harboring extended-spectrum β-lactamase genes in children with diarrhea in northwest Iran
11. Are sites of primary lesions in pemphigus vulgaris more prone to relapse?
12. Investigating the impact of added Profhilo mesogel to subcision versus subcision monotherapy in treating acne scars; a single‐blinded, split‐face randomized trial
13. Detection of Chlamydia abortus and risk factors for infection in small ruminants in Iran
14. Utility of the international society on thrombosis and hemostasis-bleeding assessment tool in the diagnosis of patients who suspected of platelet function disorders
15. molecular identification of multiple drug resistance (MDR) strain of mycobacterium tuberculosis
16. Comparing early and late treatments with rituximab in pemphigus vulgaris: which one is better?
17. Estimated cut-off values for pemphigus severity classification according to pemphigus disease area index (PDAI), autoimmune bullous skin disorder intensity score (ABSIS), and anti-desmoglein 1 autoantibodies
18. BPDAI and ABSIS correlate with serum anti-BP180 NC16A IgG but not with anti-BP230 IgG in patients with bullous pemphigoid
19. Infections In Hospitalized Patients With Psoriasis In A Skin Referral Hospital
20. Preventive Effects of Achillea Millefolium, Rosa Damascena and Origanum Majorana Hydroalcoholic Extracts on Breast Cancer in Female Mice
21. Antimicrobial Resistance, Integron Carriage, and Fluoroquinolone Resistance Genes in Acinetobacte baumannii Isolates
22. Serologic Biomarkers in Pemphigus Monitoring: C-reactive Protein, Macrophage Migration Inhibitory Factor, and Prolactin Levels Versus Autoantibody Assays.
23. Elevated serum level of B‐cell activating factor (BAFF) after rituximab therapy in pemphigus vulgaris patients suggests a possible therapeutic efficacy of B‐cell depletion therapies combined with anti‐BAFF agents
24. Anagen hair loss, anti‐desmoglein 1, and pemphigus disease area index: a significant relationship?
25. Anagener Haarverlust, Anti‐Desmoglein 1 und Pemphigus Disease Area Index: Ein signifikanter Zusammenhang?
26. Elevated serum level of B‐cell activating factor (BAFF) after rituximab therapy in pemphigus vulgaris patients suggests a possible therapeutic efficacy of B‐cell depletion therapies combined with anti‐BAFF agents.
27. Probiotic supplement as an adjunctive therapy with Ritalin for treatment of attention-deficit hyperactivity disorder symptoms in children: a double-blind placebo-controlled randomized clinical trial
28. Characteristics and outcomes of COVID-19 in patients with autoimmune bullous diseases: A retrospective cohort study
29. Comparing efficacy and safety of potassium hydroxide 5% solution with 5-fluorouracil cream in patients with actinic keratoses: a randomized controlled trial.
30. Evaluating the Persian versions of two psoriatic arthritis screening questionnaires early arthritis for psoriatic patients questionnaire (EARP) and psoriasis epidemiology screening tool (PEST) in Iranian psoriatic patients
31. A Multivariate Analysis Model of Changes in Some Laboratory Parameters in Response to COVID-19, Diabetes, Gender, and Age
32. Evaluating the efficacy and safety of topical sirolimus 0.2% cream as adjuvant therapy with pulsed dye laser for the treatment of port wine stain: A randomized, double‐blind, placebo‐controlled trial
33. Oral isotretinoin combined with topical clobetasol 0.05% and tacrolimus 0.1% for the treatment of frontal fibrosing alopecia: a randomized controlled trial.
34. Comparing efficacy and safety of potassium hydroxide 5% solution with 5-fluorouracil cream in patients with actinic keratoses: a randomized controlled trial
35. Autoimmune Bullous Disease Quality of Life (ABQoL) questionnaire: Validation of the translated Persian version in pemphigus vulgaris
36. Spatial Survival Analysis of Initiation Age and Prevalence of Smoking in Iran; Results from a Population Based Study
37. Oral isotretinoin combined with topical clobetasol 0.05% and tacrolimus 0.1% for the treatment of frontal fibrosing alopecia: a randomized controlled trial
38. Serum Levels of Interleukin 18 and Interleukin 10 in Iranian Patients with Bullous Pemphigoid and their Correlation with BP180-NC16a and BP230
39. Prevalence of the Integrons and ESBL Genes in Multidrug-Resistant Strains of Escherichia coli Isolated from Urinary Tract Infections, Ardabil, Iran.
40. A study of severe cutaneous adverse drug reactions in Iranian patients.
41. Evaluating the efficacy and safety of topical sirolimus 0.2% cream as adjuvant therapy with pulsed dye laser for the treatment of port wine stain: A randomized, double‐blind, placebo‐controlled trial.
42. Treatment of port wine stains with 595-nm pulsed dye laser in 27 pediatric patients: A prospective study in the Iranian population
43. Co-administration and Evaluation of Immune Responses of Three DNA Vaccines Encoding Immunogenic Antigens from Mycobacterium tuberculosis
44. Illness perception of patients with pemphigus vulgaris
45. Efficacy and safety of biosimilar rituximab in patients with pemphigus vulgaris: a prospective observational study
46. Assessing the correlation between trichoscopic features in lichen planopilaris and lichen planopilaris activity index
47. Lichen planopilaris: retrospective study on the characteristics and treatment of 291 patients
48. Determine the prevalence of gestational diabetes in Ardakan and its related factors
49. Comparing early and late treatments with rituximab in pemphigus vulgaris: which one is better?
50. Efficacy and safety of biosimilar rituximab in patients with pemphigus vulgaris: a prospective observational study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.